कृपया अन्य खोज का प्रयास करें
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Koen Hoffman | 54 | 2018 | Independent Non-Executive Chairman |
Michael K. McGarrity | 59 | 2019 | CEO & Executive Director |
Regine Slagmulder | 55 | 2020 | Independent Non-Executive Director |
Gerrit A. Meijer | - | - | Member of Scientific Advisory Board |
Jonathan I. Epstein | - | 2011 | Member of Scientific Advisory Board |
James G. Herman | - | - | Member of Scientific Advisory Board |
Jan Groen | 62 | 2010 | Advisor to the Board |
Donnie M. Hardison | 71 | 2021 | Independent Non-Executive Director |
Eric M. Wallen | - | 2011 | Member of Scientific Advisory Board |
Hilde Windels | 57 | 2017 | Independent Non-Executive Director |
Godelieve Verplancke | 64 | 2017 | Independent Non-Executive Director |
Eric Bednarski | - | 2020 | Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है